<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000833'>Impaired glucose tolerance</z:hpo> (IGT) was standardized in 1979 by the National <z:mp ids='MP_0002055'>Diabetes</z:mp> Data Group and the World Health Organization as a risk factor for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, replacing groups such as 'borderline' and 'chemical' <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>IGT was defined by a blood/plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> value 2 h after a 75 g <z:chebi fb="105" ids="17234">glucose</z:chebi> load that was clearly abnormal but did not convey a risk of <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> in those with non-diabetic fasting blood/plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels </plain></SENT>
<SENT sid="2" pm="."><plain>IGT is not uncommon, having a prevalence of 2-25% in adults </plain></SENT>
<SENT sid="3" pm="."><plain>Determinants include age, <z:hpo ids='HP_0001513'>obesity</z:hpo> (total and central), family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, physical inactivity and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels </plain></SENT>
<SENT sid="4" pm="."><plain>The main clinical significance of IGT is: (1) as a risk factor for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, with 20-50% of individuals developing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> over 10 years; (2) as a risk factor for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>); and (3) as a component of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>IGT can be treated and this may prevent or delay progression to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, though the effect of treatment on the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> is unknown </plain></SENT>
</text></document>